By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Aeris Therapeutics, Inc. 

10K Gill Street

Woburn  Massachusetts  01801  U.S.A.
Phone: 781-937-0110 Fax: 781-937-0077



Company News
Bay Area's Pulmonx, Inc. Snaps Up Aeris Therapeutics, Inc. for Undisclosed Amount 1/8/2015 7:12:50 AM
Hilco Streambank Hired To Conduct Asset Sale For Aeris Therapeutics, Inc. 1/24/2014 10:37:00 AM
Aeris Therapeutics, Inc.’ AeriSeal® System Clinical Data Demonstrate Improved Lung Function for up to One Year in Advanced Emphysema Patients, Publication Accepted in CHEST 6/21/2012 10:53:08 AM
Aeris Therapeutics, Inc. Receives US Patent 8,198,365 with Broad Claims to Methods of Non-Surgical Lung Volume Reduction 6/13/2012 10:56:16 AM
Aeris Therapeutics, Inc.'s AeriSeal(R) System Receives Expanded EU Approval for Advanced Emphysema Therapy 9/6/2011 9:40:21 AM
Aeris Therapeutics, Inc. Bolsters Executive Management Team with Key Appointments for Initial Commercialization of Advanced Emphysema Therapy 6/28/2011 10:56:02 AM
Aeris Therapeutics, Inc. Receives US Patent 7,819,908 with Broad Claims to Use of Energy or Heat for Non-Surgical Lung Volume Reduction 11/23/2010 10:26:22 AM
Aeris Therapeutics, Inc. Announces CE Mark Approval for the AeriSeal(R) Emphysematous Lung Sealant System 9/20/2010 7:09:56 AM
Kuros Biosurgery AG and Aeris Therapeutics, Inc. Announce Exclusive License Agreement in the Field of Lung Volume Reduction 9/23/2008 6:48:19 AM
Aeris Therapeutics, Inc. Announces Phase 2 Trial Results for Non-Surgical Emphysema Treatment 9/3/2008 8:58:25 AM